Global Bio-chem Technology Group Company Limited
0809.HK · HKSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | HK$1 | HK$1 | HK$1 | HK$1 |
| % Growth | 7.6% | 22.7% | 26.3% | – |
| Cost of Goods Sold | HK$1 | HK$1 | HK$1 | HK$1 |
| Gross Profit | HK$0 | HK$0 | HK$0 | HK$0 |
| % Margin | 13.6% | 13.8% | 7.3% | 11.5% |
| R&D Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| G&A Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| SG&A Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| Sales & Mktg Exp. | HK$0 | HK$0 | HK$0 | HK$0 |
| Other Operating Expenses | HK$0 | HK$0 | -HK$0 | -HK$0 |
| Operating Expenses | HK$0 | HK$0 | HK$0 | HK$0 |
| Operating Income | HK$0 | -HK$0 | -HK$0 | -HK$0 |
| % Margin | 2.2% | -0.2% | -10% | -12.5% |
| Other Income/Exp. Net | -HK$0 | HK$1 | -HK$0 | HK$4 |
| Pre-Tax Income | -HK$0 | HK$1 | -HK$0 | HK$4 |
| Tax Expense | HK$0 | -HK$0 | HK$0 | -HK$0 |
| Net Income | -HK$0 | HK$1 | -HK$0 | HK$4 |
| % Margin | -13% | 84.1% | -17.6% | 602.9% |
| EPS | -0.017 | 0.1 | -0.018 | 0.48 |
| % Growth | -117.4% | 665% | -103.7% | – |
| EPS Diluted | -0.017 | 0.1 | -0.018 | 0.48 |
| Weighted Avg Shares Out | 9 | 9 | 9 | 9 |
| Weighted Avg Shares Out Dil | 9 | 9 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | HK$0 | -HK$0 | HK$0 | -HK$0 |
| Interest Expense | HK$0 | HK$0 | HK$0 | HK$0 |
| Depreciation & Amortization | HK$0 | HK$0 | HK$0 | HK$0 |
| EBITDA | HK$0 | HK$0 | HK$0 | HK$4 |
| % Margin | 4.8% | 4.3% | 11.3% | 604.1% |